Table 1.
Vaccine | Patients | Dose (mcg) | Volume (mL) | Schedule (mo) |
Engerix-B | < 11 yr | 10 | 0.5 | 0, 1, 6 |
(GlaxoSmithKline, Research Triangle Park, NC) | 11-19 yr | 10 | 0.5 | 0, 1, 6 |
> 20 yr | 20 | 1.0 | 0, 1, 6 | |
Dialysis | 40 | 2.0 | 0, 1, 2, 6 | |
Recombivax HB (Merk & Co. Inc., Whitehouse Station, NJ) | < 11 yr | 5 | 0.5 | 0, 1, 6 |
11-19 yr | 5 | 0.5 | 0, 1, 6 | |
> 20 yr | 10 | 1.0 | 0, 1, 6 | |
Predialysis/ dialysis | 40 | 1.0 | 0, 1, 6 |